Trademark: 90536502
Status Date
Wednesday, December 20, 2023
Filing Date
Friday, February 19, 2021
Published for Opposition
Tuesday, November 2, 2021
5 Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders
The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Dec 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2023
Sou Extension 4 Granted
Dec 20, 2023
Sou Extension 4 Filed
Dec 20, 2023
Sou Teas Extension Received
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Extension 3 Granted
Jun 27, 2023
Sou Extension 3 Filed
Jun 27, 2023
Sou Teas Extension Received
Dec 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 24, 2022
Sou Extension 2 Granted
Dec 24, 2022
Sou Extension 2 Filed
Dec 24, 2022
Sou Teas Extension Received
Jun 24, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2022
Sou Extension 1 Granted
Jun 22, 2022
Sou Extension 1 Filed
Jun 22, 2022
Sou Teas Extension Received
Dec 28, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 2, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 2, 2021
Published For Opposition
Oct 13, 2021
Notification Of Notice Of Publication E-Mailed
Sep 25, 2021
Approved For Pub - Principal Register
Sep 14, 2021
Assigned To Examiner
May 21, 2021
New Application Office Supplied Data Entered
Feb 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
